Lakewood-Amedex (LABT) Stock Price, Quote, News & History

Key Statistics

Open

$2.23

$2.50

Volume / Avg.

13.66M / 1.44M

Day Range

$2.22 - $2.58

52 Wk Range

1.66 - 98.20

Market Cap

$7.37M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.61%

Days to Cover

Recent Lakewood-Amedex Biotherapeutics Inc News

Crude Oil Gains 2%; GE Vernova Shares Fall After Q2 Earnings

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining more than 200 points on Wednesday. The Dow traded up 0.40% to 52,432.64 while the NASDAQ declined 0.01% to 25,834.80. The

Avi Kapoor

Nasdaq Down Over 100 Points; AT&T Shares Gain After Upbeat Earnings

US stocks mixed, Nasdaq falls 100 pts. Dow up 0.02%, Nasdaq down 0.52%, S&P 500 falls 0.20%. Energy up 1.1%, tech down 0.7%. AT&T up 4% on earnings.

Avi Kapoor

Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update

Lakewood-Amedex Biotherapeutics shares were trading higher Monday but have reversed lower after the company announced data for Nu-3.

Dylan Berman

Why MaxLinear Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

MaxLinear Inc (MXL) shares jump 34.3% in pre-market trading after reporting strong Q1 results and giving high Q2 sales guidance. Other gainers include CAST, ITOC, LABT, FCHL, INTC, WKC, PDFS, and LNAI. Losers include AIXI, SKLZ, AUUD, and EUDA.

Avi Kapoor

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market session. The company's market cap stands at $5.4 million. Alamar Biosciences (NASDAQ:ALMR) stock rose 7.4% to $32.8.

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.49M

Investing Cash Flow (TTM)

-2.00M

Financing Cash Flow (TTM)

6.80M

Free Cash Flow (TTM)

-3.49M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.32M

Valuation Metrics

Enterprise Value

$967.18K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

1.26

Earnings Yield % (TTM)

-139.80%

Earnings Yield % (FWD)

-241.30%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.83

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.58M

Debt to Equity

0.02

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.23

$2.50

Volume / Avg.

13.66M / 1.44M

Day Range

$2.22 - $2.58

52 Wk Range

1.66 - 98.20

Market Cap

$7.37M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.61%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-re...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

LABT

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

LABT

ABBV

FAQ

How do I buy Lakewood-Amedex (LABT) stock?

You can purchase shares of Lakewood-Amedex (NASDAQ:LABT) through any online brokerage.

View our list of the best stock brokerages

Who are Lakewood-Amedex (LABT) competitors?

Other companies in Lakewood-Amedex’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Lakewood-Amedex (LABT) stock?

There is no analysis for Lakewood-Amedex to provide a consensus price target.

What is the current price for Lakewood-Amedex (LABT)?

The stock price for Lakewood-Amedex (NASDAQ: LABT) is $3.11 last updated August 31, 2026 at 7:59 PM EDT.

Does Lakewood-Amedex (LABT) pay a dividend?

There are no upcoming dividends for Lakewood-Amedex.

When is Lakewood-Amedex (NASDAQ:LABT) reporting earnings?

Lakewood-Amedex does not have any upcoming earnings scheduled.

Is Lakewood-Amedex (LABT) going to split?

There is no upcoming split for Lakewood-Amedex.

What sector and industry does Lakewood-Amedex (LABT) operate in?

Lakewood-Amedex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Benzinga

Benzinga

Lakewood-Amedex Biotherapeutics Inc (LABT) Stock Price, Quote, News & History

Key Statistics

Recent Lakewood-Amedex Biotherapeutics Inc News

Crude Oil Gains 2%; GE Vernova Shares Fall After Q2 Earnings

Nasdaq Down Over 100 Points; AT&T Shares Gain After Upbeat Earnings

Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update

Why MaxLinear Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's After-Market Session

Financials

Cash Flows

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Lakewood-Amedex (LABT) stock?

Who are Lakewood-Amedex (LABT) competitors?

What is the forecast, or price target, for Lakewood-Amedex (LABT) stock?

What is the current price for Lakewood-Amedex (LABT)?

Does Lakewood-Amedex (LABT) pay a dividend?

When is Lakewood-Amedex (NASDAQ:LABT) reporting earnings?

Is Lakewood-Amedex (LABT) going to split?

What sector and industry does Lakewood-Amedex (LABT) operate in?